Login
Home / CSPHF : OTC
Follow Compare
AI Analysis Fundamentals Valuation Video Analysis News Similar
Quarterly Quarterly (TTM) Annually

AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

CStone Pharmaceuticals

$0.91 +$0.02 (+2.02%)
OTC · 11 Sep 2026 20:00 UTC
Previous Close
$0.91
Day Range
$0.91$0.91
Year Range
$0.59$1.01
Market Cap
1.46B
AVG Volume
3.47K
Trailing/Forward PE
-18.45/0.44
PEG ratio
0.02
Dividend Yield
-
Next Earnings Date
2027-04-01
Primary Exchange
Other OTCUS
Revenue (CNY)
0100M200M300M21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Net Income (CNY)
-1.5B-1B-500M0500M21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Operating Income (CNY)
-1.5B-1B-500M021 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
EBITDA (CNY)
-1.5B-1B-500M0500M21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Cash Flows (CNY)
-800M-600M-400M-200M021 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
EPS (CNY)
-1-0.75-0.5-0.2500.2521 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Expenses (CNY)
-500M0500M1B1.5BR&DSG&ACapex21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Cash & Debt (CNY)
0500M1B1.5B2BCashLong Term DebtShort Term Debt21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Debt ratios
012321 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Margins
-200%-100%0%100%21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Return on Capital
-150%-100%-50%0%50%21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Shares Outstanding
0500M1B1.5B2B21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Book Value Per Share (CNY)
00.511.521 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Total Assets (CNY)
01B2B3B21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Free Cash Flow Yield
-50%-40%-30%-20%-10%0%med -10.15%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
Price to Sales
05101520med 9.48Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
Price to Book
0102030med 13.25Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
CStone Pharmaceuticals
CSPHF
Stockpicker

Video analysis: CSPHF

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: CSPHF

CStone Pharmaceuticals Enters into Exclusive Commercialization Agreement with Arrotex for Sugemalimab across Australia and New Zealand

prnewswire.com · 25 Jun 2026

CStone Pharmaceuticals Enters into Exclusive Commercialization Agreement with Arrotex for Sugemalimab across Australia and New Zealand

Arrotex, the pharmaceutical commercialization platform of DBG, Australia's leading diversified healthcare group, will be responsible for the registration, market access, and commercialization of sugemalimab in Australia and New Zealand. This partnership marks sugemalimab's fifth international commercialization partnership, further expanding the product's global footprint.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.